Novel Viral Vectors for Gene Therapy 2023

doi:10.3390/books978-3-7258-0529-7

Format

Hardback

License and Copyright

Keywords

sickle cell disease; thalassemia; globin gene therapy; γ-globin lentiviral vector; HbF; HPFH enhancers; -117 HPFH type; CD34⁺ hematopoietic stem cells; viral vector; gene therapy; cancer; chronic disease; vaccines; preclinical models; clinical trials; approved drugs; brain tumour; oncolytic virus; receptor; therapy; AAV8; VLP; nES GEMMA; DMA; cryo-TEM; gene therapy; reovirus; oncolytic virus; oncolytic viral therapy; Ras pathway; chemotherapy; reovirus; oncolytic virus; oncolytic viral therapy; stemness; pluripotency; cytolysis; reprogramming; innate immune; adeno-associated virus; lentivirus; adenovirus; adenovirus vector; replication-competent adenovirus; limiting dilution; animal-origin-free culture media; adenovirus; viral vector; vaccine; SARS-CoV-2; spike protein; genetically modified organisms (GMOs); viral vectors; virucidal activity; suspension tests; virus inactivation; disinfection; AAV; vector; adeno-associated virus (AAV); novel serotype; porcine capsid; bovine capsid; luciferase imaging; transduction; n/a

Reprint

Download Flyer

Novel Viral Vectors for Gene Therapy 2023

Edited by

March 2024

214 pages

ISBN978-3-7258-0530-3 (Hardback)
ISBN978-3-7258-0529-7 (PDF)

https://doi.org/10.3390/books978-3-7258-0529-7

Free Download (PDF)

This is a Reprint of the Special Issue Novel Viral Vectors for Gene Therapy 2023 that was published in

Biology & Life Sciences

Medicine & Pharmacology

Public Health & Healthcare

Summary

Viral vectors are gene transfer tools assembled from the backbones of naturally occurring viruses. These replication-incompetent vehicles transfer assigned payloads into eukaryotic cells. Numerous viral vector systems that influence cells or tissues have been used to perform basic and preclinical research. Some virus-derived vectors found their way into clinical practice.